The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Open accessAbstract
BACKGROUND: It is unknown whether warfarin or aspirin therapy is superior for patients with heart failure who are in sinus rhythm. METHODS: We designed this trial to determine whether warfarin (with a target international normalized ratio of 2.0 to 3.5) or aspirin (at a dose of 325 mg per day) is a better treatment for patients in sinus rhythm who have a reduced left ventricular ejection fraction (LVEF). We followed 2305 patients for up to 6 years (mean [±SD], 3.5±1.8). The primary outcome was the time to the first event in a composite end point of ischemic stroke, intracerebral hemorrhage, or death from any cause. RESULTS: The rates of the primary outcome were 7.47 events per 100 patient-years in the warfarin group and 7.93 in the aspirin group (hazard ratio with warfarin, 0.93; 95% confidence interval [CI], 0.79 to 1.10; P=0.40). Thus, there was no significant overall difference between the two treatments. In a time-varying analysis, the hazard ratio changed over time, slightly favoring warfarin over aspirin by the fourth year of follow-up, but this finding was only marginally significant (P=0.046). Warfarin, as compared with aspirin, was associated with a significant reduction in the rate of ischemic stroke throughout the follow-up period (0.72 events per 100 patient-years vs. 1.36 per 100 patient-years; hazard ratio, 0.52; 95% CI, 0.33 to 0.82; P=0.005). The rate of major hemorrhage was 1.78 events per 100 patient-years in the warfarin group as compared with 0.87 in the aspirin group (P<0.001). The rates of intracerebral and intracranial hemorrhage did not differ significantly between the two treatment groups (0.27 events per 100 patient-years with warfarin and 0.22 with aspirin, P=0.82). CONCLUSIONS: Among patients with reduced LVEF who were in sinus rhythm, there was no significant overall difference in the primary outcome between treatment with warfarin and treatment with aspirin. A reduced risk of ischemic stroke with warfarin was offset by an increased risk of major hemorrhage. The choice between warfarin and aspirin should be individualized. (Funded by the National Institute of Neurological Disorders and Stroke; WARCEF ClinicalTrials.gov number, NCT00041938.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Self-citationAntithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Self-citationWarfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction
Loh, E., Sutton, M. S. J., Wun, C.-C. C., Rouleau, J. L., Flaker, G. C., Gottlieb, S. S., Lamas, G. A., Moyé, L. A., Goldhaber, S. Z., & Pfeffer, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360403 · Cited by 602
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Circulation · doi:10.1161/circ.113.10.e409 · Cited by 541
Self-citationvan Es, R. F., Jonker, J. J., Verheugt, F. W., Deckers, J. W., & Grobbee, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09409-6 · Cited by 423
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M., Jafri, S. M., Krol, W. F., O'Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 408
Self-citationCleland, J. G. F., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
Uretsky, B. F., Thygesen, K., Armstrong, P. W., Cleland, J. G., Horowitz, J. D., Massie, B. M., Packer, M., Poole-Wilson, P. A., & Ryden, L. (2000) · Circulation · doi:10.1161/01.cir.102.6.611 · Cited by 334
Self-citationFat-suppressed breath-hold magnetic resonance coronary angiography.
Manning, W. J., Li, W., Boyle, N. G., & Edelman, R. R. (1993) · Circulation · doi:10.1161/01.cir.87.1.94 · Cited by 282
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
Hall, D., Zeitler, H., & Rudolph, W. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90449-w · Cited by 237
Al-Khadra, A. S., Salem, D. N., Rand, W. M., Udelson, J. E., Smith, J. J., & Konstam, M. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00006-0 · Cited by 227
Efficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., Toutouzas, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 217
Incidence of thromboembolic events in congestive heart failure
Dunkman, W. B., Johnson, G. R., Carson, P. E., Bhat, G., Farrell, L., & Cohn, J. N. (1993) · Circulation · Cited by 197
Dunkman, W. B., Johnson, G. R., Carson, P. E., Bhat, G., Farrell, L., & Jn, C. (1993) · PubMed · Cited by 185
Freudenberger, R. S., Hellkamp, A. S., Halperin, J. L., Poole, J., Anderson, J., Johnson, G., Mark, D. B., Lee, K. L., & Bardy, G. H. (2007) · Circulation · doi:10.1161/circulationaha.106.661397 · Cited by 169
Self-citationPullicino, P. M., Thompson, J. L. P., BARTON, B. A., Levin, B. L., Graham, S., & Freudenberger, R. S. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.07.007 · Cited by 120
Self-citationSpaulding, C. M., Charbonnier, B., Solal, A. C., Juillière, Y., Kromer, E. P., Ben-Hamda, K., Cador, R., & Weber, S. (1998) · Circulation · doi:10.1161/01.cir.98.8.757 · Cited by 113
Dicumarol Prophylaxis of Thromboembolic Disease in Congestive Heart Failure
Harvey, W. P., & Finch, C. A. (1950) · New England Journal of Medicine · doi:10.1056/nejm195002092420603 · Cited by 106
A STUDY OF THE BENEFICIAL EFFECTS OF ANTICOAGULANT THERAPY IN CONGESTIVE HEART FAILURE
GRIFFITH, G. C., Stragnell, R., Levinson, D. C., Moore, F. J., & Ware, A. G. (1952) · Annals of Internal Medicine · doi:10.7326/0003-4819-37-5-867 · Cited by 96
Anderson, G., & Hull, E. (1950) · American Heart Journal · doi:10.1016/0002-8703(50)90129-3 · Cited by 84
Antithrombotics for left-ventricular impairment?
Ezekowitz, M. D. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78610-4 · Cited by 18
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationPowers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Metadata
- Authors
- Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., Ammon, S. E., Graham, S., Sacco, R. L., Mann, D. L., Mohr, J. P., Massie, B. M., Labovitz, A. J., Anker, S. D., Lok, D. J., Ponikowski, P., Estol, C. J., Lip, G. Y. H., Di Tullio, M. R., Sanford, A. R., Mejia, V., Gabriel, A. P., del Valle, M. L., & Buchsbaum, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-17
- Volume
- 366
- Issue
- 20
- Pages
- 1859-1869
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102355502
- Cited by
- 584
- References
- 27
- FWCI
- 37.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.